Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/2012 → 31/01/2014 |
A randomised Phase II feasibility trial of [18F]fluorothymide and [18F]FDG in the assessment of systemic therapy response in triple negative breast cancer in its utility compared to conventional MRI imaging response , early ADC change and biopsy derived biomarkers
- Tutt, Andrew (Primary Investigator)
- O'Doherty, Michael (Co-Investigator)
Project: Research